Membranous glomerulonephritis risk factors: Difference between revisions
No edit summary |
|||
| Line 21: | Line 21: | ||
*The most potent risk factor in the development of [disease name] is drugs. Other risk factors include penicilliamine and captopril. | *The most potent risk factor in the development of [disease name] is drugs. Other risk factors include penicilliamine and captopril. | ||
=== Common Risk Factors ===<ref name="pmid1551252">{{cite journal |vauthors=Furuta T, Seino J, Saito T, Sato H, Agatsuma J, Ootaka T, Satoh T, Yoshinaga K |title=Insulin deposits in membranous nephropathy associated with diabetes mellitus |journal=Clin. Nephrol. |volume=37 |issue=2 |pages=65–9 |date=February 1992 |pmid=1551252 |doi= |url=}}</ref> | === Common Risk Factors === | ||
* It includes drugs and infections. <ref name="pmid1551252">{{cite journal |vauthors=Furuta T, Seino J, Saito T, Sato H, Agatsuma J, Ootaka T, Satoh T, Yoshinaga K |title=Insulin deposits in membranous nephropathy associated with diabetes mellitus |journal=Clin. Nephrol. |volume=37 |issue=2 |pages=65–9 |date=February 1992 |pmid=1551252 |doi= |url=}}</ref> | |||
*Common risk factors in the development of membranous glomerulonephritis include:<ref name="pmid9175062">{{cite journal |vauthors=Tse WY, Howie AJ, Adu D, Savage CO, Richards NT, Wheeler DC, Michael J |title=Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases |journal=Nephrol. Dial. Transplant. |volume=12 |issue=5 |pages=1017–27 |date=May 1997 |pmid=9175062 |doi= |url=}}</ref> | *Common risk factors in the development of membranous glomerulonephritis include:<ref name="pmid9175062">{{cite journal |vauthors=Tse WY, Howie AJ, Adu D, Savage CO, Richards NT, Wheeler DC, Michael J |title=Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases |journal=Nephrol. Dial. Transplant. |volume=12 |issue=5 |pages=1017–27 |date=May 1997 |pmid=9175062 |doi= |url=}}</ref> | ||
**Gold. | **Gold. | ||
Revision as of 17:15, 16 July 2018
|
Membranous glomerulonephritis Microchapters |
|
Differentiating Membranous glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranous glomerulonephritis risk factors On the Web |
|
American Roentgen Ray Society Images of Membranous glomerulonephritis risk factors |
|
Directions to Hospitals Treating Membranous glomerulonephritis |
|
Risk calculators and risk factors for Membranous glomerulonephritis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
- The most potent risk factor in the development of [disease name] is drugs. Other risk factors include penicilliamine and captopril.
Common Risk Factors
- It includes drugs and infections. [1]
- Common risk factors in the development of membranous glomerulonephritis include:[2]
- Gold.
- Penicilliamine.
- Captopril.
- Systemic Lupus Erythematousus
Less Common Risk Factors
- Less common risk factors in the development of membranous glomerulonephritis include:
- Sickle cell anemia
- Sarcoidosis
References
- ↑ Furuta T, Seino J, Saito T, Sato H, Agatsuma J, Ootaka T, Satoh T, Yoshinaga K (February 1992). "Insulin deposits in membranous nephropathy associated with diabetes mellitus". Clin. Nephrol. 37 (2): 65–9. PMID 1551252.
- ↑ Tse WY, Howie AJ, Adu D, Savage CO, Richards NT, Wheeler DC, Michael J (May 1997). "Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases". Nephrol. Dial. Transplant. 12 (5): 1017–27. PMID 9175062.